Trial intelligence / Profile preview

UGSB vs IV Narcotics for Supracondylar Fractures in Children

NCT02056288Phase 4Terminated

Sponsor
Baylor College of Medicine
Start
Mar 2011
Primary completion
Feb 2019
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Baylor College of Medicine. Started Mar 2011; status: terminated.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02056288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02056288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call